Chromosomal rearrangements involving ALK have been identified as an oncogenic driver in 3–7% of patients with NSCLC and have been associated with non-smoking status, younger age, and adenocarcinoma histology [8]. Here, ALK is linked to non-small cell lung carcinoma.